Regulators said the risk of getting Guillain-Barré syndrome from the Johnson & Johnson COVID-19 vaccine was low.
, which are the main goals of COVID-19 vaccination.
“The risk of severe adverse events after COVID-19 vaccination remains rare,” the CDC said in a statement. “Everyone age 12 years and older is recommended to receive a COVID-19 vaccine.” The FDA said it revised its fact sheets for health providers and vaccine recipients of the Johnson & Johnson vaccine to include a warning about GBS.earlier this year over concerns about extremely rare blood clots among some recipients.
Over 184 million people have gotten at least one dose of a COVID-19 vaccine across the U.S. so far, including the Pfizer and Moderna vaccines, which require two doses. Coronavirus cases and deaths have plummeted in the U.S. since vaccinations became widely available in the spring, and currently the overwhelming majority of cases are among people who have not been vaccinated.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
What To Know About The J&J COVID Vaccine And Guillain-Barre SyndromeReports say the FDA may put a warning on the J&J shot after some people developed a rare disorder. Here's why you shouldn't panic.
Read more »
CDC, FDA investigating possible J&J vaccine link to rare neurological disorderFederal health officials are looking into 'around 100 preliminary reports' of a rare but potentially serious neurological problem in people who have received J&J's Covid vaccine; more than 12.8 million J&J doses that have been administered in the U.S.
Read more »
FDA expected to add Guillain-Barre syndrome warning to J&J Covid shotThe FDA is preparing to add a warning to Johnson & Johnson's Covid-19 vaccine after receiving preliminary reports of patients developing the rare neurological condition Guillain-Barré syndrome
Read more »
J&J confirms it's talking to FDA about risk of Guillain-Barre syndrome with its Covid-19 vaccineAccording to a CNN medical analyst, a third of new Covid-19 cases are coming from five hot spots: Florida, Louisiana, Arkansas, Missouri and Nevada. Follow here for the latest news on vaccines and the Delta variant.
Read more »
Declining Vaccine Efficacy—Particularly Among Older Individuals—Prompting Pfizer’s Emergency Booster Request, Former FDA Chief SaysDr. Scott Gottlieb says the United States 'probably missed the window' to provide the follow-up doses before a summer wave of infections.
Read more »
Pfizer, U.S. Officials to Discuss COVID-19 Vaccine BoosterPfizer and top U.S. health officials will meet today to discuss FDA authorization of a third vaccine dose that would act as a booster shot against COVID-19.
Read more »